von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects - The Hoorn study

被引:264
作者
Jager, A
van Hinsbergh, VWM
Kostense, PJ
Emeis, JJ
Yudkin, JS
Nijpels, G
Dekker, JM
Heine, RJ
Bouter, LM
Stehouwer, CDA
机构
[1] Free Univ Amsterdam Hosp, Dept Internal Med, NL-1081 HV Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Inst Res Extramural Med, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Cardiovasc Res Inst, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Dept Biostat & Epidemiol, Amsterdam, Netherlands
[5] TNO Prevent & Hlth, Gaubius Lab, Leiden, Netherlands
[6] UCL, Sch Med, Dept Med, Ctr Diabet & Cardiovasc Risk, London W1N 8AA, England
关键词
von Willebrand factor; C-reactive protein; cardiovascular mortality; non-insulin-dependent diabetes mellitus; acute phase reactant;
D O I
10.1161/01.ATV.19.12.3071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increased levels of von Willebrand factor (vWf) and C-reactive protein (CRP) predict cardiovascular mortality in selected populations. It is uncertain whether vWf and CRP predict mortality in a general population and whether vWf and CRP predict mortality through similar pathways. This study investigated the association of vWf and CRP with cardiovascular and all-cause mortality among diabetic and nondiabetic subjects. An age-, sex-, and glucose tolerance-stratified sample (n=631) of a population-based cohort aged 50 to 75 years was followed prospectively for 5 years. After 5 years of follow-up, 58 subjects had died (24 of cardiovascular causes). vWf (>1.56 IU/mL) and CRP (>2.84 mg/L) levels in the upper tertile were associated with, respectively, a 3- and 2-fold increase in cardiovascular mortality after adjustment for age, sex, and glucose tolerance status. Analyses in nondiabetic and diabetic subjects separately gave similar results. After further adjustment for hypertension, levels of HDL cholesterol and triglyceride, smoking habits, ischemic heart disease, and peripheral arterial disease, the relative risks (RRs) were 3.0 (95% CI 1.2 to 7.9) for vWf and 1.4 (95% CI 0.6 to 3.5) for CRP. When both vWf and CRP were included in the latter multivariate analysis, the RRs were 3.0 (95% CI. 1.1 to 7.9) for vWf and 1.3 (95% CI 0.5 to 3.4) for CRP. The association between vWf and risk of cardiovascular mortality was independent of blood group (O versus non-O) and, moreover, similar among subjects with different blood groups. Repeating the analyses for all-cause mortality gave similar results for CRP. For vWf, the RR was 2.0 (95% CI 1.1 to 3.5) after adjustment for all other risk factors. Increased levels of vWf are independently associated with cardiovascular and all-cause mortality in both diabetic and nondiabetic subjects. The association between increased levels of CRP and cardiovascular mortality was partly explained by other risk factors. Mutual adjustment of vWf and CRP did not markedly change the results, favoring the hypothesis that vWf and CRP predict mortality through different pathways.
引用
收藏
页码:3071 / 3078
页数:8
相关论文
共 54 条
  • [11] EFFECTS OF C-REACTIVE PROTEIN ON HUMAN NEUTROPHIL GRANULOCYTES CHALLENGED WITH N-FORMYL-METHIONYL-LEUCYL-PHENYLALANINE AND PLATELET-ACTIVATING FACTOR
    FILEP, J
    FOLDESFILEP, E
    [J]. LIFE SCIENCES, 1989, 44 (08) : 517 - 524
  • [12] Prospective study of hemostatic factors and incidence of coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study
    Folsom, AR
    Wu, KK
    Rosamond, WD
    Sharrett, AR
    Chambless, LE
    [J]. CIRCULATION, 1997, 96 (04) : 1102 - 1108
  • [13] CROSS-LINKED FIBRIN DEGRADATION PRODUCTS, PROGRESSION OF PERIPHERAL ARTERIAL-DISEASE, AND RISK OF CORONARY HEART-DISEASE
    FOWKES, FGR
    LOWE, GDO
    HOUSLEY, E
    RATTRAY, A
    RUMLEY, A
    ELTON, RA
    MACGREGOR, IR
    DAWES, J
    [J]. LANCET, 1993, 342 (8863) : 84 - 86
  • [14] FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
  • [15] HAMSTEN A, 1986, BRIT HEART J, V55, P58
  • [16] INCREASED PLASMA-LEVELS OF A RAPID INHIBITOR OF TISSUE PLASMINOGEN-ACTIVATOR IN YOUNG SURVIVORS OF MYOCARDIAL-INFARCTION
    HAMSTEN, A
    WIMAN, B
    DEFAIRE, U
    BLOMBACK, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (25) : 1557 - 1563
  • [17] Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5
  • [18] FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY
    HENNEKENS, CH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) : 129 - 135
  • [19] INGERSLEV J, 1987, SCAND J CLIN LAB INV, V47, P143
  • [20] Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects -: Five-year follow-up of the Hoorn study
    Jager, A
    Kostense, PJ
    Ruhé, HG
    Heine, RJ
    Nijpels, G
    Dekker, JM
    Bouter, LM
    Stehouwer, CDA
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) : 617 - 624